Mental health care in the United States faces a persistent challenge: millions of people struggle with depression, anxiety, or PTSD, and traditional treatments often fall short. Against this backdrop, Nue Life, a Miami-based mental wellness company founded in 2021, has emerged as an innovative player in the psychedelic therapy space. The company provides at-home ketamine therapy programs designed to accelerate relief while supporting patients with a digital ecosystem that includes mood tracking, voice journaling, curated music playlists, and virtual integration sessions.
From the first consultation to ongoing support, Nue Life blends pharmacological intervention with technological and psychosocial tools. Patients can participate in the Reset program, a structured six-session ketamine treatment accompanied by coaching and digital guidance, aiming to produce meaningful improvements in mental health in weeks rather than months. Internal company data indicates that patients who engage with the full suite of support tools experience approximately 20–25% better outcomes than those using ketamine alone.
In 2023, the company was acquired by Beckley Waves, a venture studio focused on psychedelic research and therapy, forming NueCo Holdings PBC. This acquisition reflects a broader trend in mental health care: combining cutting-edge science with scalable digital platforms to reach patients across the country. By 2023, Nue Life had served over 10,000 patients across 23 states, offering a glimpse of how telehealth and psychedelic-assisted therapies might intersect to improve accessibility and efficacy.
Despite these advances, the company has faced challenges. Recent operational changes have led to service inconsistencies, with some patients reporting provider changes and communication issues. Still, testimonials from clients who have completed the programs highlight transformative experiences, from managing long-standing PTSD triggers to achieving emotional stability after decades of struggle.
The Rise of At-Home Ketamine Therapy
Ketamine, originally an anesthetic, has been studied for its rapid antidepressant effects and ability to reduce symptoms of treatment-resistant depression and PTSD. Unlike traditional antidepressants, which often take weeks to yield noticeable effects, ketamine can produce relief within hours. Nue Life leverages these properties, offering legally prescribed ketamine in a home setting under remote supervision.
The company’s programs combine medical oversight with digital tools that facilitate therapeutic engagement. Patients monitor progress using Nue Score, a proprietary metric tracking mood, behavior, and response to therapy. They can also record thoughts and reflections through voice journals, access playlists created by trained musicologists to enhance the experience, and join virtual integration sessions with trained coaches.
This hybrid approach exemplifies a broader shift in mental health care: blending pharmacology, technology, and psychosocial support to create a more comprehensive and accessible treatment model. By integrating these elements, Nue Life aims to maximize therapeutic outcomes while minimizing barriers to care.
Core Offerings and Support Programs
Nue Life’s primary services revolve around structured ketamine therapy programs:
Reset Program: An initial six-session course of at-home ketamine treatments with guidance from licensed providers and support through coaching and integration.
Ongoing Support: Patients can continue with follow-up sessions, virtual coaching, and personalized guidance to sustain therapeutic gains.
Digital Companion App: The app provides Nue Score tracking, journaling capabilities, playlists, and other tools to enhance and monitor therapy. Internal data shows that patients utilizing these features experience 20–25% improved outcomes.
The combination of medication, coaching, and digital engagement aims to replicate the benefits of in-clinic therapy while offering flexibility and comfort. This structure allows patients to undergo treatment in a familiar environment while remaining closely monitored by licensed professionals.
Company Background and Growth
Founded in 2021 as Nue Life Health, the company quickly raised $23 million in 2022, signaling investor confidence in the potential of telehealth-integrated ketamine therapy. The funding supported expansion of operations, program development, and digital platform enhancements.
In 2023, Nue Life was acquired by Beckley Waves, a psychedelic-focused venture studio. This merger formed NueCo Holdings PBC, a public benefit company designed to scale safe, legally compliant psychedelic-assisted therapies across the United States. By that year, Nue Life had reached over 10,000 patients in 23 states, reflecting rapid adoption and growing demand for alternative mental health solutions.
The acquisition aimed to leverage Beckley Waves’ broader infrastructure, including research, training programs, and clinical networks, to improve accessibility, safety, and integration of ketamine therapy into everyday mental health care.
Patient Experiences and Testimonials
Nue Life has garnered praise from many patients for its approach. Testimonials highlight significant improvements in mood, reduction in anxiety, and effective management of PTSD triggers. One patient described relief after decades of chronic symptoms, citing the professionalism of staff and the safe, structured process of the Reset program.
However, not all experiences have been seamless. Following operational and staffing changes in 2025, some patients reported challenges with communication, provider continuity, and program delivery. User discussions on platforms such as Reddit noted canceled appointments and service inconsistencies, reflecting the difficulties of scaling personalized care while maintaining high standards.
These contrasting experiences underscore the complexity of delivering mental health care remotely, particularly in a rapidly evolving field that merges psychedelic therapy with digital health solutions.
The Role of Technology in Psychedelic Therapy
A key differentiator for Nue Life is its digital platform, which functions as both a treatment tool and a support system. By tracking progress through the Nue Score, facilitating reflection through voice journaling, and enhancing therapeutic sessions with music playlists, the company seeks to deepen patient engagement and optimize outcomes.
The integration of technology allows for personalized feedback and continuous monitoring, helping clinicians adjust treatment plans and patients stay connected to support networks. This digital component is increasingly critical in psychedelic-assisted therapies, where integration and reflection are essential for lasting change.
Challenges and Ethical Considerations
While Nue Life offers a compelling model for at-home ketamine therapy, it faces ongoing challenges:
Operational Consistency: Staff changes and provider turnover have led to service inconsistencies for some patients.
Accessibility vs. Oversight: Remote therapy raises questions about patient safety and the adequacy of monitoring.
Digital Reliance: While the app enhances engagement, technical glitches and user interface limitations can hinder the experience.
Ethical considerations also remain central. Ensuring that patients receive evidence-based care, safeguarding privacy, and maintaining transparency about potential risks are critical for companies operating at the intersection of mental health, psychedelics, and technology.
Conclusion
Nue Life exemplifies the potential and complexity of the emerging field of at-home psychedelic therapy. Its combination of ketamine treatments, digital tools, and structured support programs offers hope to patients who have struggled with traditional mental health approaches. At the same time, operational challenges and patient-reported inconsistencies highlight the difficulties of scaling personalized care in a digital-first environment.
As Nue Life integrates into Beckley Waves’ larger psychedelic ecosystem, its journey will continue to shed light on how technology and innovation can transform mental health care — and where the boundaries of accessibility, safety, and efficacy must be carefully maintained.
FAQs
What conditions does Nue Life treat?
Nue Life focuses on depression, anxiety, and PTSD through at-home ketamine therapy combined with digital support.
How does the Nue Life app support therapy?
It offers mood tracking, voice journaling, curated playlists, and integration session guidance to enhance therapeutic outcomes.
Is at-home ketamine therapy safe?
Under medical supervision and proper protocols, ketamine therapy is considered safe and effective for eligible patients.
Who acquired Nue Life?
Beckley Waves acquired Nue Life in 2023, forming NueCo Holdings PBC to scale psychedelic-assisted therapy programs.
Does insurance cover Nue Life treatments?
Coverage is limited; most at-home ketamine therapy programs are currently paid out-of-pocket.
